<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>PURPOSE: The aim of the therapeutic trial was to try to optimize the treatment of severe and moderate <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> in children who lack a suitable bone marrow donor using the most successful available drugs, with the least amount of side effects </plain></SENT>
<SENT sid="1" pm="."><plain>PATIENTS AND METHODS: A pilot study for the treatment of severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> in children was conducted by four institutions </plain></SENT>
<SENT sid="2" pm="."><plain>The treatment protocol included antithymocyte globulin (ATG), <z:chebi fb="0" ids="8382">prednisone</z:chebi>, and <z:chebi fb="0" ids="4031">cyclosporine</z:chebi> A </plain></SENT>
<SENT sid="3" pm="."><plain>Twelve patients were enrolled, and 11 were evaluable </plain></SENT>
<SENT sid="4" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> patients had severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (SAA); three had <z:hpo ids='HP_0012115'>hepatitis</z:hpo>-induced severe <z:hpo ids='HP_0001915'>aplastic anemia</z:hpo> (HI-SAA) </plain></SENT>
<SENT sid="5" pm="."><plain>RESULTS: Of 11 evaluable patients, eight have responded with normalization of their blood counts </plain></SENT>
<SENT sid="6" pm="."><plain>Two of the three patients with HI-SAA responded to the therapy </plain></SENT>
<SENT sid="7" pm="."><plain>CONCLUSION: The results of our pilot study compare favorably with previous therapeutic trials </plain></SENT>
<SENT sid="8" pm="."><plain><z:hpo ids='HP_0000001'>All</z:hpo> the patients who responded achieved complete response, i.e., restoration of blood counts to within the <z:mpath ids='MPATH_458'>normal</z:mpath> range </plain></SENT>
</text></document>